ADVAIRDISKUS (GlaxoSmithKline LLC)
Welcome to the PulseAid listing for the ADVAIR drug offered from GlaxoSmithKline LLC. This Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | GlaxoSmithKline LLC |
| NON-PROPRIETARY NAME: | fluticasone propionate and salmeterol |
| SUBSTANCE NAME: | SALMETEROL XINAFOATE; FLUTICASONE PROPIONATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
| ROUTE: | RESPIRATORY (INHALATION) |
| DOSAGE FORM: | POWDER |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2001-02-28 |
| END MARKETING DATE: | 0000-00-00 |
ADVAIR DISKUS HUMAN PRESCRIPTION DRUG Details:
| Item Description | ADVAIR DISKUS from GlaxoSmithKline LLC |
| LABELER NAME: | GlaxoSmithKline LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50; 100(ug/1; ug/1) |
| START MARKETING DATE: | 2001-02-28 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0173-0695_9863e3d5-b50c-467f-b383-622b39bfad97 |
| PRODUCT NDC: | 0173-0695 |
| APPLICATION NUMBER: | NDA021077 |
Other SALMETEROL XINAFOATE; FLUTICASONE PROPIONATE Pharmaceutical Manufacturers / Labelers:
